![]() |
Home | Donate | Site map | Contact us |
|||||
![]() |
![]() |
![]() |
![]() |
![]() |
||


Dr John Pimanda, Prince of Wales Clinical School, NSW, 2010 GIA recipient
In 2010, the Leukaemia Foundation is investing more than $4 million in research projects nationally. This includes 8 new PhDs, 3 Fellowships, 1 Honours Project and 13 Grants-in-Aid as well as supporting ongoing projects.
The Leukaemia Foundation collaborates with various external organisations to fund vital research into the causes, epidemiology, diagnosis and treatment, psychosocial impact and ultimately cures for leukaemias, lymphomas, myeloma and related blood disorders.
Professor Ken Bradstock, Chair of the MSAC
The Medical and Scientific Advisory Committee (MSAC) was established in 2000 to provide strategic advice to the Leukaemia Foundation on medical, scientific, research and clinical matters. Members of the MSAC are drawn from the Australian scientific and medical research community and are each highly regarded in their fields of expertise.
The Leukaemia Foundation funds vital research into the causes, epidemiology, diagnosis and treatment, psychosocial impact and ultimately cures for leukaemias, lymphomas, myeloma and related blood disorders.
Drs Maria Askmyr and Louise Purton
St Vincents Institute, VIC
2010 GIA recipients
The Leukaemia Foundation's vision is to help find better treatments and cures for the 45,000 Australians who will be diagnosed with leukaemia, lymphoma, and myeloma and related blood cancers and disorders in the next 5 years. For this reason, the Foundation annually invests at least $3.1 million into research.
Dale Watkins, IMVS, SA, 2010 PhD scholar
The NRP seeks to foster innovative research into the causes, diagnosis and treatment of blood cancers like leukaemia, lymphoma, myeloma and related blood disorders. The program includes grants-in-aid to provide seed funding for novel research projects, whilst our fellowships and scholarships program aims to encourage talented young scientists, medical graduates and researchers to pursue a career in basic, applied or translational research to find cures and better ways to care for patients and families living with haematological malignancies.